Abstract
We describe a 6-year-old female patient with systemic lupus erythematosus (SLE) manifested mainly as steroid-dependent thrombocytopenia who developed a vasculitic appearing rash on her palms and soles following treatment with intravenous immunoglobulin (IVIg) (1 gm/kg/infusion x 2, 1 day apart). Vascular occlusion resulting in ischemic gangrene of the fore and midfeet eventually developed, necessitating bilateral amputation. This and other side effects described in SLE indicate that exacerbation of SLE, with the possibility of vasculitis, may occur following IVIg therapy.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Amputation, Surgical
-
Child
-
Drug Therapy, Combination
-
Female
-
Follow-Up Studies
-
Foot / blood supply
-
Foot / surgery
-
Gangrene / etiology*
-
Gangrene / surgery
-
Glucocorticoids / therapeutic use
-
Humans
-
Immunoglobulins, Intravenous / adverse effects*
-
Lupus Erythematosus, Systemic / complications
-
Lupus Erythematosus, Systemic / pathology
-
Lupus Erythematosus, Systemic / therapy*
-
Thrombocytopenia / complications
-
Thrombocytopenia / pathology
-
Thrombocytopenia / therapy*
-
Vasculitis / chemically induced*
-
Vasculitis / complications
-
Vasculitis / pathology
Substances
-
Glucocorticoids
-
Immunoglobulins, Intravenous